Case number 1:19-cv-01238
Bayer Intellectual Property GMBH et al v. Accord Healthcare, Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 10, 2019 | 22 | SO ORDERED (2) Docket Text: ORDER granting Stipulation of Dismissal [21] by Bayer and Accord. Signed by Judge Timothy Belcher Dyk on 12/9/2019. |
| Dec 4, 2019 | 21 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 19, 2019 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Samuel Ruggio, Manish K. Mehta, and Zaiba Baig for Accord Healthcare, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d), Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (sam) |
| Nov 18, 2019 | 17 | SO ORDERED (2) Docket Text: ORDER granting [13] MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta. Signed by Judge Timothy Belcher Dyk on 11/15/2019. |
| Nov 18, 2019 | 18 | SO ORDERED (2) Docket Text: ORDER granting [14] MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig filed by Accord Healthcare Limited, Intas Pharmaceuticals Limited, Accord Healthcare, Inc. Signed by Judge Timothy Belcher Dyk on 11/15/2019. |
| Nov 18, 2019 | 19 | SO ORDERED (2) Docket Text: ORDER granting [15] MOTION for Pro Hac Vice Appearance of Attorney Samuel Ruggio filed by Accord Healthcare Limited, Intas Pharmaceuticals Limited, Accord Healthcare, Inc. Signed by Judge Timothy Belcher Dyk on 11/15/2019. |
| Nov 18, 2019 | 20 | SO ORDERED (2) Docket Text: ORDER granting [16] Third STIPULATION TO EXTEND TIME to Answer Complaint to December 16, 2019. Signed by Judge Timothy Belcher Dyk on 11/15/2019. |
| Nov 13, 2019 | 16 | Stipulation to EXTEND Time (2) Docket Text: Third STIPULATION TO EXTEND TIME to Answer Complaint to December 16, 2019 - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Nov 12, 2019 | 13 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Manish K. Mehta - filed by Accord Healthcare Limited, Accord Healthcare, Inc., Intas Pharmaceuticals Limited. (Harmon, Kate) |
| Nov 12, 2019 | 14 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Zaiba Baig - filed by Accord Healthcare Limited, Accord Healthcare, Inc., Intas Pharmaceuticals Limited. (Harmon, Kate) |
| Nov 12, 2019 | 15 | Motion for Leave to Appear Pro Hac Vice (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Samuel Ruggio - filed by Accord Healthcare Limited, Accord Healthcare, Inc., Intas Pharmaceuticals Limited. (Harmon, Kate) |
| Nov 11, 2019 | 12 | Notice of Appearance (2) Docket Text: NOTICE of Appearance by Kate Harmon on behalf of Accord Healthcare Limited, Accord Healthcare, Inc., Intas Pharmaceuticals Limited (Harmon, Kate) |
| Oct 11, 2019 | 11 | SO ORDERED (2) Docket Text: ORDER approving STIPULATION TO EXTEND TIME 10 for Defendants to respond to the Complaint to November 14, 2019. Signed by Judge Timothy Belcher Dyk on 10/11/2019. (amf) |
| Oct 9, 2019 | 10 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to Answer Complaint to November 14, 2019 - filed by Bayer AG, Bayer Intellectual Property GMBH. (Fahnestock, Derek) |
| Aug 16, 2019 | 9 | Order (2) Docket Text: ORDER Approving D.I. [8] STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to October 15, 2019. Signed by Judge Timothy Belcher Dyk on 8/16/2019. (nmg) |
| Aug 14, 2019 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for defendants to respond to the Complaint to October 15, 2019 - filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jul 26, 2019 | 7 | Affidavit of Service (9) Docket Text: AFFIDAVIT of Service for Summons, Complaint and related papers in this action served on Accord Healthcare, Inc. on July 26, 2019, filed by Bayer AG, Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) |
| Jul 3, 2019 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Timothy Belcher Dyk of the United States Court of Appeals for the Federal Circuit. Please include the initials of the Judge (TBD) after the case number on all documents filed. (rjb) |
| Jul 1, 2019 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Accord Healthcare Limited on 7/1/2019; Accord Healthcare, Inc. on 7/1/2019; Intas Pharmaceuticals Limited on 7/1/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Jun 28, 2019 | 1 | Main Document (11) Docket Text: COMPLAINT - filed against Accord Healthcare Limited, Accord Healthcare, Inc., Intas Pharmaceuticals Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2676153.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet) (lak) |
| Jun 28, 2019 | 1 | Exhibit A (14) |
| Jun 28, 2019 | 1 | Civil Cover Sheet (1) |
| Jun 28, 2019 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Jun 28, 2019 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/25/2019. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 11/25/2021. (lak) |
| Jun 28, 2019 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (lak) |
| Jun 28, 2019 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH filed by Bayer AG, Bayer Intellectual Property GMBH. (lak) |
| Jun 28, 2019 | 6 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (lak) |
| Jun 28, 2019 | 1 | Complaint* (1) |
